Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methylation-regulated expression of HLA class I antigens in melanoma.

× No keyword cloud information.

15 in total

1. Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome.

Authors: Qian Jiang; Hong-ya Pan; Dong-xia Ye; Ping Zhang; Lai-ping Zhong; Zhi-yuan Zhang
Journal: Tumour Biol Date: 2010-06-08

Review 2. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

Authors: Robert L Ferris; Jennifer L Hunt; Soldano Ferrone
Journal: Immunol Res Date: 2005 Impact factor: 2.829

3. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

Authors: Jessica A Shafer; Conrad R Cruz; Ann M Leen; Stephanie Ku; An Lu; Alexandra Rousseau; Helen E Heslop; Cliona M Rooney; Catherine M Bollard; Aaron E Foster
Journal: Leuk Lymphoma Date: 2010-05

Review 4. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.

Authors: Luke Maggs; Ananthan Sadagopan; Ali Sanjari Moghaddam; Soldano Ferrone
Journal: Trends Cancer Date: 2021-09-03

5. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Authors: Luca Sigalotti; Alessia Covre; Elisabetta Fratta; Giulia Parisi; Francesca Colizzi; Aurora Rizzo; Riccardo Danielli; Hugues J M Nicolay; Sandra Coral; Michele Maio
Journal: J Transl Med Date: 2010-06-11 Impact factor: 5.531

Review 6. A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy.

Authors: Adam R Karpf
Journal: Epigenetics Date: 2006 Jul-Sep Impact factor: 4.528

Methylation-regulated expression of HLA class I antigens in melanoma.

1. Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome.

Review 2. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

3. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

Review 4. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.

5. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Review 6. A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy.

Review 7. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

8. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.

Review 9. Tumor evasion from T cell surveillance.

10. Defective HLA class I antigen processing machinery in cancer.